Resources

Publish Date
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on Patent Eligibility
Council for Innovation Promotion
Infographics
Idea Factories Report Infographic
Council for Innovation Promotion
Issue Briefs
Congress Should Pass PERA to Fix What the Supreme Court Unintentionally Broke
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Section 301 Investigation of Vietnam’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0364)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Section 301 Investigation of Brazil’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0331)
Council for Innovation Promotion
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on IP and the Internet
Council for Innovation Promotion
Letters
C4IP Letter to Senate Finance Committee RE: Nomination of Peter-Anthony Pappas to the U.S. International Trade Commission
Council for Innovation Promotion
Letters
C4IP Letter to Senate HELP Committee RE: Consideration of Medication Affordability and Patent Integrity Act
Council for Innovation Promotion
Letters
C4IP Letter to Senate HELP Committee RE: Medication Affordability and Patent Integrity Act Markup
Council for Innovation Promotion
External ResourcesReports
Idea Factories: How Intellectual Property Sustains and Cultivates Technology Ecosystems
Professor Jonathan Barnett
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on Medicines and IP
Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: Terminal Disclaimers
Council for Innovation Promotion
Resources:

Resources:

C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions,

08/15/2025

Resources:

Resources:

Drug Competition Enhancement Act Infographic,

06/27/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act Infographic,

06/27/2025

Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Resources:

Resources:

Drug Competition Enhancement Act,

06/25/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act,

06/24/2025

Resources:

Resources:

Reaffirm and Refine: A Government Agenda for Intellectual Property (Edition 2),

06/11/2025

Resources:

Resources:

The Congressional Innovation Scorecard: Second Edition,

06/10/2025

Resources:

Resources:

C4IP Letter to the Office of Science and Technology Policy RE: IP and Innovation,

05/09/2025

Resources:

Resources:

C4IP Letter to Senators Thom Tillis and Chris Coons RE: PERA and PREVAIL Act,

05/01/2025

Resources:

Resources:

C4IP Letter to European Commission RE: General Pharmaceutical Legislation and Patent Package,

04/23/2025

Scroll to Top